Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
62.53B | 58.03B | 56.79B | 56.30B | 52.28B | Gross Profit |
11.88B | 10.58B | 9.74B | 9.62B | 8.96B | EBIT |
1.73B | 1.93B | 1.35B | 1.22B | 725.34M | EBITDA |
3.96B | 4.34B | 3.49B | 3.91B | 3.01B | Net Income Common Stockholders |
2.99B | 1.61B | 1.61B | 1.40B | 934.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.92B | 6.24B | 4.48B | 3.26B | 2.23B | Total Assets |
76.54B | 73.03B | 68.05B | 66.19B | 66.86B | Total Debt |
3.57B | 1.38B | 1.45B | 833.82M | 1.94B | Net Debt |
-355.09M | -4.87B | -3.02B | -2.43B | -291.31M | Total Liabilities |
30.49B | 30.12B | 27.39B | 27.02B | 27.65B | Stockholders Equity |
45.86B | 42.82B | 40.59B | 39.12B | 39.17B |
Cash Flow | Free Cash Flow | |||
-1.14B | 2.44B | 1.14B | 2.82B | 1.48B | Operating Cash Flow |
1.04B | 5.78B | 3.07B | 4.30B | 2.76B | Investing Cash Flow |
-3.96B | -3.40B | -1.81B | -1.59B | -1.59B | Financing Cash Flow |
687.22M | -666.53M | 27.31M | -1.67B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥9.06B | 6.86 | 1.96% | 7.69% | 37.22% | ||
79 Outperform | ¥19.60B | 4.90 | 3.54% | 9.75% | 153.81% | ||
76 Outperform | ¥16.51B | 9.08 | 3.04% | 10.06% | 57.56% | ||
73 Outperform | ¥18.70B | 10.82 | 4.61% | 4.95% | 6.56% | ||
69 Neutral | ¥10.23B | 9.88 | 3.33% | 6.92% | -11.72% | ||
63 Neutral | $6.94B | 11.34 | 2.80% | 4.26% | 2.68% | -24.70% | |
58 Neutral | ¥2.68B | 14.08 | 6.50% | 3.53% | -144.16% |